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An electrophoretic variant of  red cell carbonic anhydrase L designated CA I 
Hiroshima-1, has been observed in 12 apparently unrelated individuals 
during a survey of 13,019 individuals from the cities of Hiroshima and 
Nagasaki, Japan. Analyses of  tryptic and chymotryptic peptide patterns of 
this CA I variant purified from 8 of the 12 individuals revealed the same 
altered peptides in each case. Examination of the amino acid sequence of an 
altered tryptic peptide purified from one of the variants showed that the 
aspartic acid residue at position 86 was replaced by a glycine residue. 
Thermostability studies demonstrated that all samples of  CA I Hiroshima-1 
were less Stable than normal CA L The specific esterase (p-nitrophenyl 
acetate) activities of  the normal and variant CA I isozymes were essentially 
the same. The difference spectra of the normal and variant enzymes were 
essentially the same. The isoelectric focusing patterns of CA I Hiroshima-1 
showed a different pattern of minor bands to those produced by normal CA 
L The relative amounts of the normal and variant enzymes purified from 
single heterozygous individuals were similar. 
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INTRODUCTION 
Three isozymes of carbonic anhydrase (termed CA I, CA II, and CA III), 
which are under the control of three separate genetic loci, have now been 
characterized from human tissues; and their chemical properties, structures, 
tissue distribution, genetic control, and evolution have been the subjects of 
several papers and reviews (cf. Lindskog et al., 1971; Carter, 1972; Tashian 
and Carter, 1976; Tashian, 1977; Pocker and Sarkanen, 1978; Carter et al., 
1979; Tashian et al., 1980a,b,c) .  
At least 20 electrophoretic variants of CA I, and seven electrophoretic 
variants of CA II, have now been discovered in the hemolysates of individuals 
from a wide variety of ethnic groups. The amino acid substitutions have been 
determined for seven of the CA I variants and one of the CA II variants (for a 
review, see Tashian et al., 1980c). As yet, no variant of human CA III (found 
mainly in red skeletal muscle) has been detected (Carter et al., 1979; 
Hewett-Emmett and Tashian, 1979). 
An electrophoretic variant of red cell CA I, originally designated CA Ih 
Hiroshima, was first reported by Ueda (1974) in two individuals from 
Hiroshima, Japan, and subsequently two more individuals from Hiroshima 
were found with what appeared to be the same variant (Ueda et al., 1977). In 
this report, we have designated the variant, CA I Hiroshima-1 (abbreviation: 
CA I HIR-1), in keeping with the nomenclature suggested by Tashian et al. 
(1980c). A preliminary chemical characterization of this variant was 
reported by Tanis et al. (1976); however, the amino acid substitution was not 
determined. During a more recent electrophoretic typing survey of red cell 
CA I and CA II carried out on individuals residing in Hiroshima and 
Nagasaki, seven additional examples of what seemed to be the CA I HIR-1 
variant were discovered from Hiroshima and one from Nagasaki. 
In the present report, we describe the amino acid substitution and some 
chemical properties of CA I Hiroshima-1. In addition, an attempt is made, 
utilizing peptide mapping techniques, to determine whether each of eight 
available samples of this variant from different individuals represent the same 
substitution. 
MATERIALS AND METHODS 
Isolation of the Variant Enzymes 
About 50 ml of whole blood was obtained from eight individuals who were 
heterozygous for CA I HIR-1. Whole blood was collected in acid-citrate- 
dextrose (ACD), washed three times with 0.85% NaC1, and stored at -70°C. 
Normal outdated bloods were obtained from the University of Michigan 
Blood Bank. 
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Purification of the variant enzymes was carried out using affinity 
chromatography on sulfonamide-bound CM-Sephadex columns by the 
method of Osborne and Tashian (1975). Further purification was achieved on 
a DEAE cellulose column (Whatman DE-32, 1 x 80 cm) equilibrated with 
0.025 M Tris-HC1, pH 8.7. CA I HIR-1 and normal CA I were then 
successively eluted with a linear 0-0.2 M NaC1 gradient. 
Eleetrophoresis  and Isoelectric  Focusing 
Starch gel electrophoresis was carried out using a borate buffer system at pH 
8.6, as previously described (Tashian and Carter, 1976). During the survey, 
the esterase activities of CA I and CA II after electrophoresis were detected 
with 4-methyl umbelliferyl acetate for CA | and fluorescein diacetate for CA 
II (Hopkinson et al., 1974). 
Polyacrylamide slab gel electrophoresis was carried out as previously 
described (King and Laemmli, 1971), and stained with a 0.3% solution of 
Coomassie Brilliant Blue R-250. SDS polyacrylamide gel electrophoresis was 
carried out essentially as described by Laemmli and Favre (1973). 
For the isoelectric focusing in polyacrylamide gel, 75 izg of purified 
normal or variant CA I was applied to an LKB Ampholine PAG plate (pH 
range 5.5-8.5), and run for 2.5 hr at 10°C with an LKB Multiphor power 
supply. 
Analysis  of  Peptide Patterns 
Peptide mapping techniques following trypsin and chymotrypsin digestion 
were performed as described by Tashian et al. (1966). Four milligrams of 
normal or variant CA I was denatured at 95°C for 3 min in 0.2 M ammonium 
bicarbonate buffer, pH 8.6, and the denatured protein washed twice with the 
same buffer. The precipitate was digested with trypsin (2% w/v) for 90 min 
at 37°C. The digest was then centrifuged for 5 min at 3000 rpm to separate 
the undigested "core," and the supernatant was applied to Whatman 3 MM 
filter paper sheets. After descending chromatography in butanol-acetic acid- 
H20 (38:9:45), electrophoresis was performed at 2000 V (120-140 mA) for 
80 min in pyridine-acetic acid-H20 (25:1:225), pH 6.4, or in formic acid- 
acetic acid-H20 (25:87:888), pH 2.0. After drying, the filter paper sheets 
were sprayed with a cadmium-ninhydrin staining solution (Heilmann et al., 
1957). The tryptic "core" was washed twice with 0.2 M ammonium bicarbon- 
ate buffer, pH 8.6, and digested with chymotrypsin (1% w/v), followed by 
descending chromatography and electrophoresis in the pH 6.4 buffer. 
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Amino Acid Sequencing 
About 10 mg of normal or variant heat denatured CA I was digested with 
trypsin (2% w/w) for 12 hr at 37°C to obtain the altered, and corresponding 
normal, ninhydrin-free pcptides for sequence analysis. The soluble tryptic 
peptides were first separated as described in the preceding section, and the 
desired peptides were located with cadmium-ninhydrin stained guide strips 
and elutcd with 10% acetic acid. The eluted peptides were further purified by 
high voltage paper electrophoresis (pH 2.0, 2000 V, 80 rain), and the peptides 
were located and eluted as above. The purified peptides were then sequenced 
in a Beckman Model 890B sequencer. The PTH amino acid steps from the 
sequencer were identified using a high performance liquid chromatography 
(HPLC) system, which consisted of a Merck RP-18 (10 #m particle size) 
reverse phase silica column (250 × 4.6 ram), an LDC UV II detector (264 
nm), and an Altex model 110 A pump. Elution of the PTH-amino acids was 
isocratic, using 40% acetonitrile/60% 0.01 M sodium acetate, pH 4.7, which is 
similar to the method used by Zimmerman et al. (1977). 
Enzyme Assays 
The csterase activity of the normal and variant CA I isozymes was measured 
by following the incrcase in absorbance at 348 nm as described by Armstrong 
et al. (1966), with p-nitrophcnyl acetate as substrate. 
Thermal Stability 
In order to obtain suitable esterase activity toward p-nitrophenyl acetate in 
the assay system, purificd normal CA I and CA I HIR-1 were diluted in 0.1 M 
Tris-sulfatc buffer, pH 7.5, and were then incubated in small capped glass 
tubes in a thermostatically controlled water bath at 57°C. At various time 
intervals, 10/A aliquots were transferred to ice cooled polypropylene micro- 
tubes containing 50 #1 of 0.01 M diethylmalonate buffer, pH 8.0. The tubes 
were then vibrated on a vortex mixer, centrifuged at 15,000 rpm for 5 rain, 
a n d  50 #1 of the supernatant was used for the cstcrase assay. 
Difference Spectra 
The difference spectra, between free and Ncoprontosil-bound enzymes, were 
determincd as previously described (Osborne and Tashian, 1974) using a 
Beckman Acta II recording spectrophotometcr equipped with a fiat-bed 
recorder at 25°C. 
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RESULTS 
The Survey 
During the course of a screening program carried out by the Radiation 
Effects Research Foundation, Hiroshima, on offspring of individuals exposed 
to atomic bomb radiation, eight individuals (seven from Hiroshima and one 
from Nagasaki) were discovered who were heterozygous for what appeared to 
be the same CA I HIR-1 variant in an overall sample of 9,140 individuals 
from Hiroshima and Nagasaki, Japan. Previously, four individuals (all from 
Hiroshima) were found with the CA I HIR-1 variant in a sample of 13,969 
individuals from Hiroshima and Nagasaki (Ueda, 1974; Ueda et al., 1977). 
Thus a total of 12 individuals, with no history of a common ancestor 
extending back two to three generations, have been found who are heterozy- 
gous for what is supposedly the same CA I HIR-1 variant in an overall sample 
of 13,019 individuals from Hiroshima (7,523) and Nagasaki (5,496). 
In the present study, 50 ml of whole blood was drawn from eight 
individuals with the CA I HIR-1 variant. The parents were available for 
testing for six of these individuals, and in each case, one of the parents was 
heterozygous for the variant, indicating that the mutation was unrelated to 
the radiation history. No family study was undertaken for the other two 
individuals. One of the eight individuals was from Nagasaki, and one of the 
remaining seven from Hiroshima was the same individual studied by Tanis et 
al. (1976). 
Purification 
The variant carbonic anhydrases were isolated from the hemolysates of the 
eight individuals who were heterozygous for the variant. A typical elution 
pattern after separation on DEAE-cellulose is shown in Fig. 1. As can be seen, 
the relative amounts of the normal and variant enzymes appear to be about 
the same. 
Eiectrophoresis 
The electrophoretic patterns of normal CA I and CA I HIR-1 in polyacryl- 
amide gels with and without SDS are shown in Fig. 2A,B. The starch gel 
electrophoretic pattern of CA I HIR-1 after each isolation step is shown in 
Fig. 2C. No minor bands were observed, indicating that the enzymes were 
homogeneous by these criteria. 
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Fig. 1. Elution profile of normal CA I; the secondary 
isozyme of CA I, CA I (+ 1); and CA I HIR-1 (see lane 
4, Fig. 2C) after chromatography on DEAE cellulose. 
Column, 1 x 90 cm; flow rate, 10 ml/br; elution buffer, 
0.025 M Tris-HC1, pH 8.7. 
Isoelectric Focusing 
The isoelectric focusing patterns of normal CA I and CA I HIR-1 are shown 
in Fig. 3. Two samples of CA I HIR-1, one from Hiroshima and the other 
from Nagasaki, exhibit the same patterns of major and minor bands and these 
in turn are different from the pattern of normal CA I. It appears that the 
amino acid replacement in CA I HIR-1 results in the production of secondary 
bands whose patterns differ from those of the normal enzyme. The isoelectric 
points of the major bands of CA I and CA I HIR-1 were estimated from the 
pH curve of the isoelectric focusing gel, and these were 6.33 and 6.87, 
respectively. 
Peptide Analyses 
Tryptic peptide patterns (two-dimensional) were prepared from the CA I 
variants which had been purified from the hemolysates of the eight individu- 
als with the CA I HIR-1 variant. 
In each of the eight variant tryptic peptide patterns, a yellow-staining 
peptide that is normally present in the neutral region of the pattern from 
normal CA I was found to have shifted toward the cathode. A typical pattern 
is shown in Fig. 4A. Assuming the altered yellow peptide differed from the 
normal yellow peptide by a charge of + 1, and since the peptide exhibited a 
migration ratio of 0.27 relative to aspartic acid, it was estimated to have a 
molecular weight of about 1000 (Offord, 1966). 
At pH 2.0, the yellow peptides from both normal CA I and CA I HIR-1 
migrate to similar positions on their respective peptide patterns, but are well 
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Fig. 2. (A and B) Protein stained (Coomassie blue) patterns of normal CA I and CA I HIR-1 
after electrophoresis in polyacrylamide gels in the absence (A) and presence (B) of 0,1% SDS. 
Lanes 1, 2, and 3 are, respectively, CA [, CA I HIR-1, and a mixture of CA I and CA I HIR-1. 
Electrophoresis carried out at  room temperature for 5 hr in 12.5% acrylamide (separating gel) 
containing 0.375 M Tris-HCI buffer, pH 8.8; stacking gel (5% acrylamide) made up in 0.125 M 
Tris-HCl buffer, pH 6.8. (C) Starch gel electrophoresis protein patterns (Nigrosin stain) of CA 
I, CA I ( +  l),  CA II, and CA I HIR-1 after different isolation steps. Lane 1, CA I after amnity 
and DEAE chromatography; lane 2, CA II after affinity chromatography (included as a 
migration reference for CA I HIR-1); lane 3, CA I HIR-1 after affinity and DEAE 
chromatography; and lane 4, CA I, CA I ( + l ) ,  and CA I HIR-!  pool from affinity 
chromatography (see Fig. 1 for source of material after DEAE separation), Vertical starch gel 
electrophoresis carried out in 0.02 M borate buffer, pH 8.6, at 4°C for 17 hr at 8 V/cm. 
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Fig. 3. Isoelectric focusing patterns of normal CA I and CA I HIR-1. Lane 1, CA I; lane 2, 
CA I HIR-1 from Hiroshima; and lane 3, CA I HIR-1 from Nagasaki. 
separated from surrounding peptides. Because of this convenient separation, 
electrophoresis was carried out at pH 2.0 in order to isolate the normal and 
altered tryptic peptides for further analyses. 
Comparisons of the chymotryptic peptide patterns from CA I HIR-1 
and normal CA I show that an anodally migrating peptide in normal CA I has 
migrated to the neutral peptide region in CA I HIR-1 (Fig. 4B). Since the 
normal (yellow stained) peptide appears to have a charge of - 1, its migration 
ratio of 0.4 relative to aspartic acid indicates that it has a molecular weight of 
about 500 (Offord, 1966). 
Amino Acid Sequence 
As shown and described in Fig. 5, the amino acid sequences of the normal and 
altered tryptic peptides were: 
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A 
CA I CA I HIR-I 
B 
CA I CA I HIR-I 
Fig. 4. Tryptic (A) and chymotryptic (B) peptide patterns of normal CA I and CA I HIR-1. 
Arrows indicate normal and variant peptides. Electrophoresis carried out at pH 6.4. 
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Fig. 5. Amino acid sequence steps of the variant tryptic peptide 
(residues 81-89) from CA I HIR-1 analyzed by HPLC elntion of 
PTH-amino acids. The sequence was the same for these residues from 
normal CA I with the e~(ception of Asp (eluting time: 2.4 rain) at step 
6. Typical elution times (min) of standard PTH-amino acids: Asp 
(2.5), Glu (3.2), Asn (3.6), Gin (3.8), Ser (4.0), Thr (4.6), Gly (5.1), 
Ala (6.4), Tyr (6.9), A Thr (8.2), Pro-1 (9.0), Val (11.6), Pro-2 
(12.3), Trp (14.9), Phe (16.9), Lys/Ile (17.8), Leu (19.6). Peaks at 
14 and 16 min probably degradation products of reagents. See text 
for procedural details. 
N o r m a l  C A  I 
C A  I HIR-1  
81 86 89 
Gly-Gly-Pro-Phe-Ser-Asp-Ser(Tyr,Arg) 
Gly-Gly-Pro-Phe-Ser-Gly-Ser-Tyr, A r g  
Examina t ion  of  the  human  C A  I sequence shows tha t  these pept ides  represent  
residues 81 to 89 (Andersson et al., 1972; Lin and Deutsch,  1973), and tha t  
the aspar ty l  res idue at  position 86 in normal  C A  I has been replaced  by a 
glycyl  residue in C A  I HIR-1  (Fig.  5). 
The  molecular  weight  of  the var ian t  t rypt ic  pept ide  is 926, which agrees  
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well with the value of 1000 estimated from its electrophoretic mobility. The 
normal and altered chymotryptic peptides are most likely residues 85-88, 
Ser-Asp-Ser-Tyr (normal) and Ser-Gly-Ser-Tyr (CA I HIR-1). The normal 
peptide has a molecular weight of 480, which agrees well with the value of 
500 estimated from its electrophoretic mobility. 
Thermal Stability 
The results of the thermal denaturation studies are shown in Fig. 6. As can be 
seen, all of the variant enzymes are less stable than normal CA I. On the basis 
of showing the same altered tryptic and chymotryptic peptides, it is assumed 
that the CA I HIR-1 variant in the individual from Nagasaki has the same 
substitution (86 Asp --~ Gly) as the other examples of CA I HIR-1; however, 
it is of interest that this sample of the variant from Nagasaki appears to be 
more stable than the other seven variant samples, as its heat denaturation 
curve lies midway between CA I and the CA I HIR-1 samples. It is therefore 
possible that the variant from Nagasaki may represent an additional altera- 
tion in its primary structure (e.g., neutral amino acid substitution), which 
confers greater stability; however, a careful reexamination of this variant 
must be undertaken before this can be clarified. 
Enzyme Activities 
The specific esterase (p-nitrophenyl acetate) activity of each of the eight 









Fig. 6. Heat  stability of normal CA I and CA I HIR-I .  
The enzymes were assayed for residual p-nitrophenyl 
acetate activity. Esterase activity of normal CA I (e); 
means and ranges for the seven samples of CA I HIR-1 
from Hiroshima (O). See text for details of procedure. 
I I I I I I 
I0 20 30 40 50 60 
TIME AT 57 ° (min.) 
546 Kageoka, Hewett-Emmett, Stroup, Yu, and Tashian 
value for the esterase activities of the eight variant samples was 19.6 _+ 3.2 
~tmol p-nitrophenol formed/min/umole CA I at 25°C (single normal control 
value, 20.4). 
Difference Spectra 
As can be seen in Fig. 7, the difference spectra for CA I and CA I HIR-1 are 
very similar. This finding suggests that the amino acid substitution does not 
affect the conformation of the active site residues. In an earlier report, the 
difference spectra of CA I and CA I HIR-1 were reported to be somewhat 
different (Tanis et al., 1976). 
DISCUSSION 
In addition to determining the amino acid replacement in one purified sample 
of CA I HIR-1, it was of interest to determine whether the other six purified 
samples of CA I HIR- 1 from Hiroshima and the one sample of CA I HIR- 1 
from Nagasaki represented the same variant allele. In all eight variant 
samples, not only did the tryptic peptides at both pH 6.4 and pH 2.0 show the 
same migration patterns, but the chymotryptic peptides also showed identical 
patterns. The fact that the isoelectric focusing pattern of the CA I HIR-1 
variant from Nagasaki is identical to the one from Hiroshima, and both are 
uniquely different from CA I (see Fig. 3), further supports the idea that it 
also has the same amino acid substitution. However, the increased thermosta- 
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Fig. 7. Difference spectra for Neoprontosil com- 
plexes of normal CA I (. • .) and CA I HIR-1 
( ). Conditions: 25°C; 0.1 M Hepes buffer, pH 
7.5; enzyme concentrations, 20 uM. 
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samples does raise the possibility that a second substitution undetected by 
peptide mapping or isoelectric focusing might be present. This individual 
should clearly be resampled and carefully reexamined. 
The aspartic acid residue at position 86 in human CA I is located on the 
outside of the molecule (Notstrand et al., 1975) and does not appear to be 
part of any secondary structure. This residue is aspartic acid in the CA I 
isozymes of chimpanzee, orangutan, rhesus macaque, and rabbit (cf. Tashian, 
1977; Contel et al., 1981; and unpublished data). However, it is of interest 
that this residue is glycine in the low activity CA I of turtle (Tashian et al., 
1981), in the CA II isozymes of human, rhesus, sheep, ox, and rabbit (of. 
Tashian, 1977, and unpublished data) and in the muscle CA III isozymes of 
human and gorilla (Hewett-Emmett and Tashian, 1979, and unpublished 
data). These findings suggest that glycine is the ancestral residue at position 
86, and that the substitution of glycine for aspartic acid at this position in CA 
I HIR-1 represents a back mutation. 
Four other variants of human CA I have been demonstrated (by direct 
comparison) to have identical electrophoretic mobilities to CA I HIR-1 at pH 
8.15 and 8.6 (cf. Tashian et al., 1980c). These are CA I Hull (225 Gln 
Arg/Lys), CA I Portsmouth (255 Thr ~ Arg), CA I Guam (253 Gly 
Arg), and CA I Montreal-2. These variants represent the most cathodally 
migrating variants of CA I with a charge of + 1 that have been examined so 
far. 
Two other electrophoretic variants of CA I, CA I Nagasaki (76 Arg 
Gin) (Goriki et al., 1979) and CA I Hiroshima-2 (Goriki et al., 1980), and 
one variant of CA II, CA II Hiroshima (K. Goriki, personal communication) 
have been discovered in the same survey of the Hiroshima and Nagasaki 
populations in which the CA I Hiroshima-1 variants were found. 
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